论文信息 - Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories - 字舞流文

Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories

I. Boyd | J. McEwen

[1] I. Boyd,et al. Near‐death of Australia's Medicines Safety Update , 2021, Internal medicine journal.

[2] Jennifer H. Martin,et al. Reporting adverse drug events to the Therapeutic Goods Administration , 2021, Australian prescriber.

[3] J. Lexchin,et al. A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States ‐ 2007 to 2016 , 2020, Pharmacoepidemiology and drug safety.

[4] Medicines And Healthcare Products Regulatory Agency , 2020, Definitions.

[5] S. Zaidi,et al. Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey , 2018, International Journal of Clinical Pharmacy.

[6] C. Furberg,et al. Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014 , 2016, Pharmacoepidemiology and drug safety.

[7] E. Roughead,et al. Adverse drug events: counting is not enough, action is needed , 2006, The Medical journal of Australia.

[8] I. Edwards,et al. Reasons for Reporting Adverse Drug Reactions—Some Thoughts Based on an International Review , 1997, Pharmacoepidemiology and drug safety.

[9] P. Feros. Pharmaceutical benefits scheme. , 1986, The Medical journal of Australia.